Overview
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $77,398 |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 60 days for 2021).
- 202514/07/2026
- 202405/08/2025
- 202330/06/2024
- 202220/07/2023
- 202113/09/2022
- 202012/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Mako Pharma holds 1 active trademark registered with the Polish Patent Office. 1 application is pending. The first mark was filed in 2016.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| SIMTAC DUO(word) | Z.464012 | 5, 10 | Protected | Nov 17, 2026 | |
| MAKO PHARMA | Z.598077 | 35, 40, 42 | Application pending | – |
| Mark | Protected until | |
|---|---|---|
| SIMTAC DUO(word) | Nov 17, 2026 | |
| MAKO PHARMA | – |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, a member of the management board acting independently is authorized to submit declarations of will on behalf of the company. If the management board is a multi-member management board, joint action by two members of the management board is required to submit declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Jagielskiage 57 | 294 | $7,941.65 | 49% |
Małgorzata Tatiana Korpusikage 53 | 306 | $8,265.80 | 51% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-04-30.
38 1020 1026 0000 1202 0217 1882
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $302,051.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,020$2,020 | PGE Obrót S.A. | |
| Dec 15, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $177.7K$177,689 | Prezes Banku Gospodarstwa Krajowego | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,958$4,958 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| INV Poland sp. z o.o.sp. k. | $5,980,381.22 | invpoland.com | ||
| BGW Pharmasp. z o.o. | $5,726,873.65 | bgwpharma.com | ||
| Hemplabsp. z o.o. | $5,520,405.66 | hemplab.pl | ||
| Badapak-Borowski, Bieganowskisp. j. | $5,153,466.67 | badapak.pl | ||
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | ||
| Browar Błoniesp. z o.o. | $4,743,773.33 | browarblonie.com | ||
| TOMA Foodsp. z o.o. | $4,132,489.45 | tomafood.eu | ||
| Bowika sp. z o.o.sp. k. | $3,993,131.30 | bowika.pl | ||
| Nikalabsp. z o.o. | $3,148,345.23 | nikalab.pl | ||
| Efferta Blendssp. z o.o. | $3,020,056.75 | efferta.pl |
Change history
| Date | Event | |
|---|---|---|
| 2013-07-02 | Share capital increase (10,000.00 PLN → 60,000.00 PLN) | |
| 2013-05-11 | Share capital reduction (100,000.00 PLN → 10,000.00 PLN) | |
| 2013-03-28 | Entered in the register |
FAQ
Last updated: 2026-07-30